Author Correction: Assessment of the cardioprotective effect of liraglutide on methotrexate induced cardiac dysfunction through suppression of inflammation and enhancement of angiogenesis in rats
R.H. Mahmoud, M.A. Mohammed, E.S. Said, E.M. Morsi, O.O. Abdelaleem, M.O. Abdel All, R.M. Elsayed, E.A. Abdelmeguid, D.E. Eldosoki Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Correction to: European Review for Medical and Pharmacological Sciences 2021; 25 (19): 6013-6024–DOI: 10.26355/eurrev_202110_26879–PMID: 34661261, published online on 15 October 2021.
After publication, the authors applied to add some corrections to the paper.
They wanted to change the second affiliation of one co-author Dr. Eman Said.
The second affiliation will be “Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia”, instead of “College of Pharmacy, Qassim University, Al-Qassim, Saudi Arabia”.
There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
R.H. Mahmoud, M.A. Mohammed, E.S. Said, E.M. Morsi, O.O. Abdelaleem, M.O. Abdel All, R.M. Elsayed, E.A. Abdelmeguid, D.E. Eldosoki
Author Correction: Assessment of the cardioprotective effect of liraglutide on methotrexate induced cardiac dysfunction through suppression of inflammation and enhancement of angiogenesis in rats
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 2
Pages: 345-345
DOI: 10.26355/eurrev_202201_27853